Streetbeat News

Price Targets

RMD

Analysts have updated their ratings and price targets for ResMed (NYSE:RMD) over the past three months, with a mix of bullish and indifferent stances. The average 12-month price target is now $188.0, up from $175.25, with a high estimate of $215.00 and a low of $160.00. ResMed's financial performance is strong, with a revenue growth rate of 16.0%, a net margin of 19.91%, an ROE of 5.24%, an ROA of 3.25%, and a low debt-to-equity ratio of 0.35. The company is well-positioned in the respiratory care device market, with a focus on digital health and a growing market due to increasing diagnoses of sleep apnea.

Portfolio Pulse from Benzinga Insights

January 25, 2024 | 6:00 pm

CTAS

Seven financial analysts have recently updated their ratings on Cintas (NASDAQ:CTAS), with a mix of bullish and indifferent stances. The average 12-month price target for CTAS has increased to $627.14, up from $568.67, with individual targets ranging from $585.00 to $660.00. Analysts from firms including Truist Securities, Stifel, JP Morgan, RBC Capital, and Deutsche Bank have raised their price targets, reflecting a positive outlook on the company's performance. Cintas, known for its uniform rental programs and facility services, has shown a revenue growth rate of 9.3%, a net margin of 15.7%, an ROE of 9.25%, and an ROA of 4.26%, with a debt-to-equity ratio of 0.72.

Portfolio Pulse from Benzinga Insights

January 25, 2024 | 6:00 pm

ISRG

Mizuho analyst Anthony Petrone has maintained a Neutral rating on Intuitive Surgical (NASDAQ:ISRG) and increased the price target from $350 to $390.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 5:15 pm

ES

Mizuho analyst Anthony Crowdell has maintained a Neutral rating on Eversource Energy (NYSE:ES) but has reduced the price target from $63 to $54.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 5:13 pm

KMPR

Kemper Corporation's stock (KMPR) is trading higher following an increase in the price target by Piper Sandler from $56 to $66.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 5:13 pm

EIX

Mizuho analyst Anthony Crowdell has maintained a Buy rating on Edison International (NYSE:EIX) but reduced the price target from $76 to $75.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 5:11 pm

DD

Mizuho analyst John Roberts has maintained a Buy rating on DuPont de Nemours (NYSE:DD) but has reduced the price target from $86 to $80.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 5:09 pm

VBTX

Stephens & Co. analyst Matt Olney has maintained an Equal-Weight rating on Veritex Holdings (NASDAQ:VBTX) but has reduced the price target from $26 to $24.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 5:06 pm

CHCO

Stephens & Co. analyst Russell Gunther has maintained an Equal-Weight rating on City Holding (NASDAQ:CHCO) and increased the price target from $98 to $100.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 5:04 pm

TFIN

Stephens & Co. analyst Matt Olney has maintained an Equal-Weight rating on Triumph Financial (NASDAQ:TFIN) but reduced the price target from $79 to $75.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 5:02 pm